Boston Scientific
BSX
BSX
630 hedge funds and large institutions have $31B invested in Boston Scientific in 2017 Q4 according to their latest regulatory filings, with 129 funds opening new positions, 215 increasing their positions, 193 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.54% less ownership
Funds ownership: 91.68% → 91.14% (-0.54%)
12% less call options, than puts
Call options by funds: $53.5M | Put options by funds: $60.8M
15% less capital invested
Capital invested by funds: $36.7B → $31B (-$5.64B)
Holders
630
Holding in Top 10
13
Calls
$53.5M
Puts
$60.8M
Top Buyers
| 1 | +$239M | |
| 2 | +$197M | |
| 3 | +$140M | |
| 4 |
D.E. Shaw & Co
New York
|
+$120M |
| 5 |
Goldman Sachs
New York
|
+$105M |
Top Sellers
| 1 | -$527M | |
| 2 | -$295M | |
| 3 | -$192M | |
| 4 |
Jennison Associates
New York
|
-$160M |
| 5 |
JPMorgan Chase & Co
New York
|
-$132M |